The estimated Net Worth of Sean P. Nolan is at least $101 Million dollars as of 16 August 2023. Mr. Nolan owns over 444,444 units of Ventas Inc stock worth over $100,317,155 and over the last 10 years he sold VTR stock worth over $0. In addition, he makes $199,009 as Independent Director at Ventas Inc.
Sean has made over 3 trades of the Ventas Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he bought 444,444 units of VTR stock worth $400,000 on 16 August 2023.
The largest trade he's ever made was buying 444,444 units of Ventas Inc stock on 16 August 2023 worth over $400,000. On average, Sean trades about 17,524 units every 76 days since 2015. As of 16 August 2023 he still owns at least 1,535,545 units of Ventas Inc stock.
You can see the complete history of Mr. Nolan stock trades at the bottom of the page.
Sean Patrick Nolan serves as Independent Director of the Company. He is an accomplished senior executive with more than 28 years of biopharmaceutical experience. He served as Chief Executive Officer and President at AveXis, Inc. (formerly NASDAQ: AVXS), a clinical-stage gene therapy company, from 2015 to 2018, successfully growing the company from four employees to a publicly listed company which was acquired by Novartis for $8.7 billion in 2018. Mr. Nolan is Chairman of a gene therapy company, Encoded Therapeutics, Inc., and Executive Chairman of Istari Oncology, Inc. He is also a member of the Board of Directors of Aquinox Pharmaceuticals Inc.
As the Independent Director of Ventas Inc, the total compensation of Sean Nolan at Ventas Inc is $199,009. There are 18 executives at Ventas Inc getting paid more, with Debra Cafaro having the highest compensation of $11,348,300.
Sean Nolan is 52, he's been the Independent Director of Ventas Inc since 2019. There are 13 older and 5 younger executives at Ventas Inc. The oldest executive at Ventas Inc is Richard Gilchrist, 74, who is the Independent Director.
Sean's mailing address filed with the SEC is C/O VENTAS, INC., 353 NORTH CLARK STREET, CHICAGO, IL, 60654.
Over the last 20 years, insiders at Ventas Inc have traded over $3,514,800,086 worth of Ventas Inc stock and bought 14,500 units worth $790,035 . The most active insiders traders include Holdings Llc Lazard Alterna..., Matthew J Lustig und Senior Quarters Llc Lazard .... On average, Ventas Inc executives and independent directors trade stock every 24 days with the average trade being worth of $15,339,027. The most recent stock trade was executed by Peter J. Bulgarelli on 10 September 2024, trading 7,500 units of VTR stock currently worth $487,875.
celebrating our 20th anniversary in 2018, ventas is an s&p; 500 company and leading real estate investment trust (reit). as the leading capital provider for healthcare real estate with more than $40 billion of investments under our belt, we own communities where patients and their families receive health and healing; where world class researchers discover treatments for disease; and where seniors live with dignity. our diverse property portfolio combines seniors housing, life science research and innovation centers, medical office buildings, health system complexes, and post-acute care facilities. thanks to our financial strength and liquidity, our stock and robust dividend provides secure retirement savings and income to pensioners, firefighters, teachers and individuals around the world. ventas takes our esg (environment, social & governance) commitments seriously, emphasizing strong corporate governance; encouraging community engagement through social and financial support to the co
Ventas Inc executives and other stock owners filed with the SEC include: